Achieve and Pagaya Launch Partnership to Expand Access to Personal Loans
Prnewswire· 2025-12-17 13:00
Premiere digital personal finance company Achieve to leverage Pagaya's credit-decisioning technology and data network to responsibly broaden access to personal loans for consumers SAN MATEO, Calif., Dec. 17, 2025 /PRNewswire/ -- Achieve, the leader in digital personal finance, and Pagaya Technologies LTD. (NASDAQ: PGY) ("Pagaya"), a global technology company delivering AI-driven product solutions for the financial ecosystem, have partnered to responsibly expand consumers' access to personal loans on Achieve ...
Moon Pursuit Capital launches $100 million market-neutral crypto fund
Yahoo Finance· 2025-12-17 13:00
Moon Pursuit Capital, a crypto-focused investment firm, is launching its second fund, a $100 million market-neutral vehicle designed to deliver what it said are consistent, risk-adjusted returns across digital asset cycles. The new fund is built around an algorithmic trading strategy that aims to stay market-neutral and generate alpha without taking a strong directional view on prices, the company said in a press release Wednesday. A market-neutral strategy is an investment approach designed to generate ...
Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference
Globenewswire· 2025-12-17 13:00
ROCKVILLE, Md. and SUZHOU, China, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management plans to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. T ...
BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S (MVP-S) in Women with Hormone Receptor Positive/HER2 Negative (HR+/HER2-) Stage II-III Breast Cancer
TMX Newsfile· 2025-12-17 13:00
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious disease, allergy, and other immune diseases based on its DPX™ antigen delivery and immune-educating technology platform, is very pleased to announce positive results from a phase 1 clinical study of maveropepimut-S ("MVP-S") along with neoadju ...
Seeing Machines Technical Paper Series on Non-Fatigue Impairment launched
Prnewswire· 2025-12-17 13:00
To support this approach, Seeing Machines is working with leading experts and universities, conducting pioneering experiments that explore the disconnect between BAC readings and actual driver impairment. These collaborations underscore the Company's commitment to developing solutions that align technological innovation with real-world safety outcomes. Part One of the Technical Paper series is now available, with future instalments set to explore additional aspects of non-fatigue impairment, including from ...
International Energy Partner Invests $5 Million in Canada’s Energy Future
Globenewswire· 2025-12-17 13:00
The $5 million investment into MAX Power from a leading conglomerate in Vietnam has officially closed and launches an international collaboration focused on accelerating Natural Hydrogen development in Saskatchewan, positioning Canada at the forefront of a new clean energy frontier. Video: Lawson – Canada’s First Big Step into Natural Hydrogen https://www.youtube.com/watch?v=lTTOwMxz_zo SASKATOON, Saskatchewan, Dec. 17, 2025 (GLOBE NEWSWIRE) -- MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) ...
SharpLink Appoints Joseph Chalom as Sole CEO and Member of the Board; Rob Phythian Steps Down Following Company's Planned Transition
Globenewswire· 2025-12-17 13:00
Minneapolis, MN, Dec. 17, 2025 (GLOBE NEWSWIRE) -- SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), one of the world’s largest corporate holders of Ether (“ETH”) and prominent industry advocate of Ethereum adoption, today announced that effective December 15, 2025 its Board of Directors has appointed Joseph Chalom as sole Chief Executive Officer and elected him to the Board. Rob Phythian has stepped down from his roles as Co-Chief Executive Officer and Director, marking the completion o ...
DoubleDown Interactive Announces Pricing of Secondary Offering by Selling Shareholder
Globenewswire· 2025-12-17 13:00
SEOUL, South Korea, Dec. 17, 2025 (GLOBE NEWSWIRE) -- DoubleDown Interactive Co., Ltd. (Nasdaq: DDI) (“DoubleDown” or the “Company”) today announced the pricing of an underwritten secondary offering of 2,330,468 American Depositary Shares (the “ADSs”), each ADS representing 0.05 common share of the Company (“Common Shares”), at a public offering price of $8.00 per ADS by STIC Special Situation Diamond Limited (the “Selling Shareholder”). The offering consists entirely of the ADSs to be sold by the Selling S ...
Canadian Natural Resources: I'm Buying Canadian Oil And NG (NYSE:CNQ)
Seeking Alpha· 2025-12-17 13:00
When you think of oil, it's not uncommon for the first thought to be of Texas, especially if you're living within the United States of America. However, if you're thinking on a global scale, you may think of Saudi Arabia, Iraq, Iran, or Russia. Often, oil production is impacted byScott Kaufman, aka Treading Softly, learned about investing firsthand from over a decade of financial sector experience. He is the lead analyst for Dividend Kings providing actionable insight into high quality dividend growing and ...
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
Globenewswire· 2025-12-17 13:00
SOMERSET, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will present the latest company updates at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 14th, 2026, at 9:00 a.m. PT. The live webcast will be available to investors and other interested parties by accessing the Investor Relations section of ...